Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04402125 · ClinicalTrials.gov registry record · NA

Reducing Stroke Risk in African-American Men

A NA study of Stroke and Transient Ischemic Attack, sponsored by Case Western Reserve University.

Completed
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT04402125 is a NA study of Stroke and Transient Ischemic Attack that has completed, run by Case Western Reserve University. The registered enrollment target is 160 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04402125, a NA study of Stroke and Transient Ischemic Attack, has completed, sponsored by Case Western Reserve University.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The project is a 6-month prospective Randomized Controlled Trial evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=80) vs. wait-list (WL, N=80) control in African American men who have experienced a stroke or TIA within the past 5 years.

Interventions

  • BEHAVIORAL TargEted MAnageMent Intervention (TEAM)

Study Locations (1)

Ohio

  • Case Western Reserve University - Cleveland

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2020-05-05
Est. Completion 2025-09-08
Phase NA

Sponsor

Case Western Reserve University

141 total trials

What the Registry Record Tells You About NCT04402125

The ClinicalTrials.gov registry entry for NCT04402125 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which TargEted MAnageMent Intervention (TEAM) is the first listed.

NCT04402125 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04402125 about?

NCT04402125 is a clinical study titled "Reducing Stroke Risk in African-American Men". The project is a 6-month prospective Randomized Controlled Trial evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=80) vs. wait-list (WL, N=80) control in African American men who have experienced a stroke or TIA within the past 5 years.

What is the current status of trial NCT04402125?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2020-05-05. Estimated completion is 2025-09-08.

What conditions does trial NCT04402125 study?

This clinical trial studies the following conditions: Stroke, Transient Ischemic Attack.

What interventions are being tested in trial NCT04402125?

The interventions under investigation include: TargEted MAnageMent Intervention (TEAM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04402125?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04402125 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.